TWICE Concludes World Tour in Seoul… “This Is For” Brings the Tour to a Close
Encore Performances at K-SPO Dome from the 10th to the 12th
44 Cities, 81 Performances: A "Record-High" Scale
A Preview of the Best Show, Summarizing 11 Years of Growth
[E-Daily Starin YUN GI BACK Reporter] The group TWICE will hold encore performances for their sixth world tour, “THIS IS FOR,” at the Seoul K-Sport Dome from the 10th to the 12th, bringing their year-long journey to a close. TWICE performing at the “THIS IS FOR” concert at Hong Kong’s Kai Tak Stadium. (Photo courtesy of JYP Entertainment) According to their agency, JYP Entertainment, on the 10th, these concerts mark the finale of TWICE’s “largest-ever” world tour. The tour, which began in Incheon last July, spanned 44 cities worldwide—including Asia, North America, and Europe—with a total of 81 performances. In particular, the group received critical acclaim for delivering an even more immersive experience by featuring a fully open 360-degree stage for every show. TWICE also set numerous new records during this tour. They became the first K-pop girl group to perform at Hong Kong’s Kai Tak Stadium, and in North America, they drew 550,000 attendees, setting the all-time record for the largest audience for a K-pop girl group. In Japan, they further solidified their global standing by holding a solo concert at the Tokyo National Stadium—a first for both a K-pop group and any foreign artist. Since launching their first tour in 2017, TWICE has performed a total of 188 shows across 59 regions worldwide through six world tours. This marks the highest number of regions and performances for a solo tour by a K-pop girl group. With each tour, they have expanded the scale of their venues from arenas to stadiums, growing into “global stadium artists.” TWICE stated, “We were able to get this far thanks to the fans who have been with us from our first world tour until now,” adding, “Since this is an encore concert, we will present the best performance yet, embodying the past 11 years.”
This week (July 13–16), startups across various sectors—including beauty brands, chat platforms, and AI-based decision-making and data infrastructure—secured investments from venture capital (VC) firm…
Here are the clinical trial and product approval updates that garnered attention in the domestic pharmaceutical and biotech industry this week (July 13–16).
(Photo: AI-generated)
CelltrionRece…
PharmaResearch(214450)is staking its future on expanding into North America—the world’s largest beauty market—despite concerns over stagnant growth in its domestic market. At the same time, attention …